Plenary Session III: Late-Breaking Clinical Trials

The Late-Breaking Clinical Trial session emphasizes the most recent and groundbreaking research in the field of neuromodulation.

Welcome

Ellen L. Air, MD PhD; Nebojsa Nick Knezevic, MD PhD

Durability of 10-kHz Spinal Cord Stimulation for Painful Diabetic Neuropathy-18-Month Multicenter Randomized Controlled Trial Results (Abstract ID# 16457)

Erika Petersen, MD

Determining the Prognostic Value of Continuous Intrathecal Infusion (Abstract ID# 16264)

Bradford Jones, DO

The influence of stimulation frequency in DRG stimulation – a double-blind randomized trial (Abstract ID# 16240)

Guilherme Santos Piedade, MD

Twelve-month outcomes from RCT: 10kHz Spinal Cord Stimulation for treating Non-surgical Refractory Back Pain (Abstract ID# 16473)

Leonardo Kapural, MD PhD

Closing Q&A Discussion

John Markman, MD

Anuj Bhatia, MD PhD

Plenary Session IV: Optimizing Neuromodulation to Improve Patient Outcomes

The practice of neuromodulation involves more than just technical proficiency. This plenary session explores some of the socioeconomic aspects of the practice of neuromodulation.

Plenary Session I: The Next Generation

In a rapidly changing medical field landscape which has rapidly adapted telehealth for aspects patient care, we will examine the current interplay between healthcare and patients via social media and telehealth and discuss pathways to improve patient education and access to neuromodulation therapies

Plenary Session II: The Future of Neuromodulation

During this session, important topics in neuromodulation will be covered, including: Psychiatric Neuroengineering, FDA Approval Standards for PCLC Systems, and Fundamentals of Physiologic Closed-Loop Control Systems.